- Publications
- Influence
Share This Author
Tissue-Specific Immunopathology in Fatal COVID-19
- D. Dorward, C. Russell, C. Lucas
- Medicine, BiologyAmerican journal of respiratory and critical care…
- 20 November 2020
TLDR
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
- F. Salguero, A. White, M. Carroll
- BiologyNature communications
- 24 February 2021
TLDR
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
TLDR
Genomes of trombidid mites reveal novel predicted allergens and laterally transferred genes associated with secondary metabolism
- Xiaofeng Dong, K. Chaisiri, B. Makepeace
- BiologyGigaScience
- 15 November 2018
TLDR
Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma.
- F. Liu, Xiaofeng Dong, Jie Li
- Biology, ChemistryOncology letters
- 1 August 2015
TLDR
T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
- Fuhai Wang, Xiaofeng Dong, Jie Li
- Biology, ChemistryOncology reports
- 1 February 2015
TLDR
Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals.
- J. Zhong, Xiaoming Yu, Xuetao Shi
- Biology, MedicineInternational journal of molecular medicine
- 1 May 2018
TLDR
Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19
- S. Moore, Rebekah Penrice-Randal, J. Hiscox
- Biology, MedicinemedRxiv
- 8 March 2020
TLDR
MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1
- Quanqing Zou, Qianli Tang, Dong Huang
- BiologyExperimental and therapeutic medicine
- 13 June 2017
TLDR
Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma
- P. Xiu, Xuesong Dong, Xueying Sun
- Biology, ChemistryCancer science
- 1 March 2013
TLDR
...
...